Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP.
10.19540/j.cnki.cjcmm.20230510.706
- Author:
Hong-Ling OU
1
;
Hui WU
2
;
Yu-Liang REN
2
;
Yuan SI
3
;
Zhong-Qi DUAN
2
;
Xue-Wen LIU
1
Author Information
1. School of Basic Medical Sciences,Hubei University of Medicine Shiyan 442000,China Hubei Key Laboratory of Wudang Local Chinese Medicine Research,Hubei University of Medicine Shiyan 442000,China.
2. School of Basic Medical Sciences,Hubei University of Medicine Shiyan 442000,China.
3. School of Basic Medical Sciences,Hubei University of Medicine Shiyan 442000,China Hubei Key Laboratory of Embryonic Stem Cell Research,Hubei University of Medicine Shiyan 442000,China.
- Publication Type:Journal Article
- Keywords:
CNOT4;
Yes-associated protein;
hydnocarpin;
invasion and migration;
triple negative breast cancer;
ubiquitin-proteasome system
- MeSH:
Humans;
Triple Negative Breast Neoplasms/metabolism*;
Matrix Metalloproteinase 2/metabolism*;
Cell Line, Tumor;
Cell Proliferation;
Cell Movement;
Ubiquitination;
RNA, Messenger/metabolism*;
Epithelial-Mesenchymal Transition;
Transcription Factors/metabolism*
- From:
China Journal of Chinese Materia Medica
2023;48(16):4483-4492
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to investigate the effect and mechanism of hydnocarpin(HC) in treating triple negative breast cancer(TNBC). Cell counting kit-8(CCK-8), xCELLigence real-time cellular analysis(RTCA), and colony formation assay were employed to determine the effects of HC on the proliferation of two TNBC cell lines: MDA-MB-231 and MDA-MB-436. The effects of HC on the migration and invasion of TNBC cells were detected by high-content analysis, wound-healing assay, and Transwell assay. The changes in the epithelial-mesenchymal transition(EMT) and the expression of invasion-and migration-associated proteins [E-cadherin, vimentin, Snail, matrix metalloproteinase-2(MMP-2), and MMP-9] were detected by Western blot. Western blot and RT-qPCR were employed to determine the protein and mRNA levels of Yes-associated protein(YAP) and downstream targets(CTGF and Cyr61). TNBC cells were transfected with Flag-YAP for the overexpression of YAP, and the role of YAP as a key target for HC to inhibit TNBC malignant progression was examined by CCK-8 assay, Transwell assay, and wound-healing assay. The pathway of HC-induced YAP degradation was detected by the co-treatment of proteasome inhibitor with HC and ubiquitination assay. The binding of HC to YAP and the E3 ubiquitin ligase Ccr4-not transcription complex subunit 4(CNOT4) was detected by microscale thermophoresis(MST) assay and drug affinity responsive target stability(DARTS) assay. The results showed that HC significantly inhibited the proliferation, colony formation, invasion, and EMT of TNBC cells. HC down-regulated the protein and mRNA levels of CTGF and Cyr61. HC down-regulated the total protein level of YAP, while it had no effect on the mRNA level of YAP. The overexpression of YAP antagonized the inhibitory effects of HC on the proliferation, migration, and invasion of TNBC cells. HC promoted the degradation of YAP through the proteasome pathway and up-regulated the ubiquitination level of YAP. The results of MST and DARTS demonstrated direct binding between HC, YAP, and CNOT4. The above results indicated that HC inhibited the malignant progression of TNBC via CNOT4-mediated degradation and ubiquitination of YAP.
